Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing
2026 · 2nd Quarter (Apr 1 - June 30)
EMD MILLIPORE CORPORATION
Filed by EMD MILLIPORE CORPORATION.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- Not reported
- Expenses
- $100,000.00
- Registrant
- EMD MILLIPORE CORPORATION
- Filing UUID
- f85c7d16-d27b-4e61-906d-3b57a7f8d338
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
General discussions related to federal procurement policy
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.